The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio enables early detection of amyloid plaques through a non-invasive blood ...

The first in vitro diagnostic device that uses blood samples to detect Alzheimer disease has been granted marketing clearance ...

In vitro diagnostics (IVDs ... "Being in the top 5 notified bodies for medical device certification, we offer extensive expertise and technical competence. Our global team of auditors, technical ...

The global in vitro diagnostics (IVD) market has exhibited significant growth, with its valuation rising from $67,111 million in 2019 to an estimated $91,093 million by 2027. This ...

In order to ensure the safety and efficacy of medical devices entering its Member States, the European Union (EU) has ...

The Europe in vitro diagnostics (IVD) market has showcased significant growth, with its valuation increasing from $13,825 million in 2019 to an anticipated $18,647 million by 2027. This report ...

The FDA has cleared first blood-based in vitro diagnostic tool for detecting Alzheimer’s disease. It is approved for use in ...

DNV, the independent assurance and risk management provider, has been recognized by the European Commission as a notified ...

The FDA has cleared the first-ever blood test for early Alzheimer's detection, which the agency says reduces the need for ...